Damascus (AFP) | 15/07/2025 - 22:06:37 | Death toll from south Syria violence rises to 203: monitor
Washington (AFP) | 15/07/2025 - 20:26:58 | Trump says Indonesia to buy 50 Boeing jets under US deal
Washington (AFP) | 15/07/2025 - 19:30:03 | Ukraine 'shouldn't target' Moscow: Trump
Damascus (AFP) | 15/07/2025 - 19:06:29 | US envoy says working to restore calm in Syria, calls clashes 'worrisome'
Damascus (AFP) | 15/07/2025 - 18:46:56 | Syria condemns Israeli strikes, holds Israel responsible for 'consequences'
Paris (AFP) | 15/07/2025 - 18:21:52 | Renault makes British executive Duncan Minto interim CEO
Beirut (AFP) | 15/07/2025 - 18:08:55 | Hezbollah calls Israel east Lebanon strike a 'major escalation'
Los Angeles (AFP) | 15/07/2025 - 17:53:54 | 'Severance' leads Emmy nominations with 27
Brussels (AFP) | 15/07/2025 - 17:30:23 | EU top diplomat says US should share 'burden' of arming Ukraine
Paris (AFP) | 15/07/2025 - 17:05:27 | France PM suggests slashing two public holidays amid budget cuts
Agence France-Presse (AFP) announced Tuesday it will open a bureau in Pyongyang, becoming only the second global news agency to establish a permanent presence in the North Korean capital.
AFP takes part to the 7th photography festival in Leipzig f/stop, Germany, from June 25th until July 3rd, 2016.
The Asian Productivity Organization (APO) convened the 67th Session of the Governing Body (GBM), 20–22 May 2025 in Jakarta, hosted by the Government of the Republic of Indonesia. This annual session brought together over 50 delegates representing APO member governments to discuss the APO’s strategic direction and ensure the organization’s continued credibility, effectiveness, and relevance amid a rapidly evolving productivity landscape. This press release features multimedia. View the full rel...
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315) today announced that the key technology of its independently developed RenMab™ fully human antibody mouse platform has been granted an invention patent by the Japan Patent Office (JPO). This milestone marks a significant step in strengthening the global intellectual property portfolio of the RenMice® fully human antibody platform family. It underscores the continued advancement of Biocytogen’s comprehensive ...
